Skip to Main Content

INFORMATION FOR

    Skin Diseases, Structural Biology & Crystallography - The Bunick Lab at Yale School of Medicine

    October 01, 2025

    Transcript

    • 00:05The skin is the largest
    • 00:07organ in the body. And
    • 00:09not only is it a
    • 00:10barrier, but it has a
    • 00:11very active immune system. When
    • 00:13we think of inflammatory
    • 00:14skin disorders, psoriasis, when we
    • 00:16think of atopic dermatitis, they
    • 00:18all have a component of
    • 00:19skin barrier disruption.
    • 00:21And so many of the
    • 00:22diseases in dermatology become a
    • 00:24vicious cycle between skin barrier
    • 00:26disruption and inflammation.
    • 00:28Patients also experience things like
    • 00:30itch,
    • 00:31burning, stinging, and it affects
    • 00:33their quality of life. And
    • 00:35my job as the scientist
    • 00:37is understanding how to break
    • 00:38this loop.
    • 00:46In the big picture, my
    • 00:47laboratory is doing what is
    • 00:48called structural biology. We are
    • 00:50trying to understand the structure
    • 00:52of how proteins,
    • 00:54nucleic acids, and other macromolecules
    • 00:56work in the skin and
    • 00:58how drugs that target different
    • 01:00skin diseases work. And then
    • 01:02in certain genetic diseases where
    • 01:04those proteins
    • 01:05are in error, we want
    • 01:07to understand what has gone
    • 01:08wrong and how can we
    • 01:09fix
    • 01:11it. There's no one else
    • 01:12in dermatology
    • 01:13that is running a primary
    • 01:14NIH funded research lab that's
    • 01:17dedicated to structural biology and
    • 01:19answering those difficult
    • 01:20biochemistry
    • 01:21questions through the approaches of
    • 01:23extra crystallography,
    • 01:25cryo electron microscopy, and if
    • 01:27needed, nuclear magnetic resonance imaging.
    • 01:33So extra crystallography
    • 01:35is a particular technique that
    • 01:37allows you to understand the
    • 01:38atomic level structure
    • 01:40of proteins, nucleic acids, and
    • 01:42their complexes.
    • 01:44What you have to do
    • 01:44in crystallography is take a
    • 01:46very pure protein, for example,
    • 01:48and put it in the
    • 01:49right solution
    • 01:50that allows it to precipitate.
    • 01:52And when it does it
    • 01:53just right, it forms a
    • 01:54crystal. And that crystal is
    • 01:56a perfectly
    • 01:58aligned lattice of lots and
    • 02:00lots of molecules of that
    • 02:01protein of interest. And then
    • 02:03when you hit that crystal
    • 02:04with x rays, that crystal
    • 02:06then diffracts
    • 02:07the light. And then what
    • 02:09we can do is use
    • 02:10mathematical
    • 02:10approaches to take that diffraction
    • 02:12pattern and turn it into
    • 02:14actually a three-dimensional
    • 02:15model
    • 02:16of that protein, and that
    • 02:17allows us to determine the
    • 02:19structure at that atom and
    • 02:20bond level. And then we
    • 02:21can take that information and
    • 02:23ask those critical questions. What
    • 02:25does this tell us about
    • 02:26helping the human patient?
    • 02:33One of the wonderful things
    • 02:34about being a physician scientist
    • 02:36is I get to see
    • 02:37what it's like in the
    • 02:38lab to make a discovery,
    • 02:40but I also get to
    • 02:41talk to patients face to
    • 02:42face. And I really get
    • 02:43an understanding of what matters
    • 02:45to them.
    • 02:46And the advantage of this
    • 02:47is it allows me to
    • 02:48then come back from a
    • 02:50translational perspective and understand
    • 02:52what is going to help
    • 02:54deliver better patient care. This
    • 02:57is also why I really
    • 02:58am excited to be a
    • 02:59part of clinical trials here
    • 03:00in dermatology
    • 03:01at Yale.
    • 03:03I love helping patients. I
    • 03:05love it when patients feel
    • 03:07better and are happier with
    • 03:08themselves.
    • 03:09In the end, all of
    • 03:10what we do, whether it's
    • 03:11the research mission,
    • 03:13the clinical mission, or even
    • 03:14a clinical trial mission, it's
    • 03:16all about advancing patient care,
    • 03:18developing new therapies for rare
    • 03:20genetic skin diseases for which
    • 03:22patients have nothing yet.